GTS SECURITIES LLC
Broker-DealerPosition in APLS — Apellis Pharmaceuticals, Inc.
CIK 1452765
NEW YORK, NY
Position in APLS
as of Mar 31, 2026
· filed May 15, 2026
Position Value
$627,748
+$300,068 QoQ
Shares Held
15,604
+37.3% QoQ
Ownership
0.012%
of shares outstanding
% of Portfolio
0.06%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Jun 2023
7 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in APLS Over Time
Shares Held
Position Value (USD)
Derivatives in APLS
reported options exposure · as of Sep 30, 2024CallValue
$204,764
CallShares
7,100
PutValue
$337,428
PutShares
11,700
Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.
Position in Biotechnology
Healthcare · as of Mar 31, 2026GTS SECURITIES LLC holds $7,337,364 across 30 Biotechnology names. APLS ranks #3 (8.6% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
1,738 | $776,086 | |
| 2 | ACLX |
Arcellx, Inc.
|
6,338 | $727,729 | |
| 3 | APLS |
Apellis Pharmaceuticals, Inc.
This page
|
15,604 | $627,748 | |
| 4 | REGN |
Regeneron Pharmaceuticals, Inc.
|
767 | $592,614 | |
| 5 | CRSP |
CRISPR Therapeutics AG
|
7,787 | $370,427 | |
| 6 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
1,052 | $348,075 | |
| 7 | INSM |
INSMED Inc
|
1,991 | $325,568 | |
| 8 | ABVX |
Abivax S.A.
|
2,652 | $295,300 |
All Filings in APLS
Export CSV
13 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $627,748 | 15,604 | Shares | Defined | 2026-05-15 | |
| 2024-09-30 | $204,764 | 7,100 | Call | Defined | 2024-11-13 | |
| 2024-09-30 | $337,428 | 11,700 | Put | Defined | 2024-11-13 | |
| 2024-09-30 | $327,680 | 11,362 | Shares | Defined | 2024-11-13 | |
| 2024-06-30 | $312,902 | 8,157 | Shares | Defined | 2024-08-14 | |
| 2024-03-31 | $323,113 | 5,497 | Shares | Defined | 2024-05-15 | |
| 2023-12-31 | $7,039,536 | 117,600 | Call | Defined | 2024-02-15 | |
| 2023-12-31 | $3,115,533 | 52,047 | Shares | Defined | 2024-02-15 | |
| 2023-12-31 | $13,264,976 | 221,600 | Put | Defined | 2024-02-15 | |
| 2023-09-30 | $7,474,860 | 196,500 | Call | Defined | 2023-11-15 | |
| 2023-09-30 | $6,116,832 | 160,800 | Put | Defined | 2023-11-15 | |
| 2023-09-30 | $1,399,643 | 36,794 | Shares | Defined | 2023-11-15 | |
| 2023-06-30 | $1,305,371 | 14,329 | Shares | Defined | 2023-08-16 | |
| No filing history on record for this holder in this stock. | ||||||